Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 3 Adenoma 2 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Thrombocytopenia 1 Soft Tissue Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myocardial Infarction 1 Multiple Myeloma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematuria 1 Hematologic Diseases 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Adenomatous Polyps 1 Adenocarcinoma of Lung 1 Acute Coronary Syndrome 1

Interventions

Capecitabine 35 Oxaliplatin 32 Fluorouracil 29 Leucovorin 26 Irinotecan 22 Bevacizumab 19 Cetuximab 17 Radiotherapy 16 Radiation 11 Surgical Procedures, Operative 6 Radiotherapy, Intensity-Modulated 5 Gene Expression Profiling 5 Chemotherapy, Adjuvant 5 Celecoxib 5 Neoadjuvant Therapy 4 Immunohistochemistry 4 Biopsy 4 Amplified Fragment Length Polymorphism Analysis 4 cediranib 3 Reverse Transcriptase Polymerase Chain Reaction 3 Receptor Protein-Tyrosine Kinases 3 Folfox protocol 3 Drug Therapy 3 Cisplatin 3 sargramostim 2 regorafenib 2 pembrolizumab 2 fludarabine phosphate 2 aldesleukin 2 Surveys and Questionnaires 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Rectal Neoplasms × Aspirin × Clear all

NCT03170115 2020-12-17

ICAR

Instituto Nacional de Cancer, Brazil

Phase 2 Terminated

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡